A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

NCT05698524 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Recurrent High Grade Glioma
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Glioblastoma
Gliosarcoma

Interventions

DRUG: PCI 24781
DRUG: Temozolomide

Sponsor

University of Nebraska

Collaborators

[object Object]